Volume 7, Issue 5

HBV Spring 2020: State of the Research

In this issue:

Although vaccines to prevent hepatitis B acquisition have long existed, a “cure” for those infected has rarely been achieved. But new insights into the life cycle of the virus, as well as improved knowledge about how to boost a host’s immune system to clear HBV, are pointing the way to potential new therapies.   

In this issue, Dr. Marion Peters from Northwestern University analyzes the current literature in this rapidly moving area and brings us up to date on the status of HBV research as of Spring of 2020. 

Learning objectives:

  • Describe the current research into understanding the hepatitis B viral replication life cycle. 
  • Discuss which aspects of the HBV life cycle are targets of some of the new agents under investigation. 

Author:

Marion Peters, MD
Marion Peters, MD

Adjunct Professor of Medicine 
Northwestern University
Chicago, IL

Program Directors:

Mark S. Sulkowski, MD

Professor of Medicine
Division of Infectious Diseases
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology and Hepatology
Johns Hopkins School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD

Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP
The Johns Hopkins Hospital
​Baltimore, Maryland

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: May 22, 2020
Expiration date: May 21, 2022